Your browser doesn't support javascript.
loading
The cost of cancer care: how far would you go for a trial?
Fitzpatrick, Orla M; Murphy, Catherine; Duignan, Erica; Egan, Keith; Hennessy, Bryan T; Grogan, Liam; Murphy, Adrian; Breathnach, Oscar S; Naidoo, Jarushka; Morris, Patrick G.
Afiliação
  • Fitzpatrick OM; Cancer Clinical Trials and Research Unit, Medical Oncology Department, Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland. orlafitzpatrick@rcsi.com.
  • Murphy C; Cancer Clinical Trials and Research Unit, Medical Oncology Department, Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland.
  • Duignan E; Cancer Clinical Trials and Research Unit, Medical Oncology Department, Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland.
  • Egan K; Cancer Clinical Trials and Research Unit, Medical Oncology Department, Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland.
  • Hennessy BT; Cancer Clinical Trials and Research Unit, Medical Oncology Department, Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland.
  • Grogan L; Cancer Clinical Trials and Research Unit, Medical Oncology Department, Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland.
  • Murphy A; Cancer Clinical Trials and Research Unit, Medical Oncology Department, Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland.
  • Breathnach OS; Cancer Clinical Trials and Research Unit, Medical Oncology Department, Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland.
  • Naidoo J; Cancer Clinical Trials and Research Unit, Medical Oncology Department, Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland.
  • Morris PG; Cancer Clinical Trials and Research Unit, Medical Oncology Department, Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland.
Ir J Med Sci ; 191(6): 2487-2491, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35038110
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Tipo de estudo: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ir J Med Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irlanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Tipo de estudo: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ir J Med Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irlanda